Declan

Importance of whole genomic profiling 🧬 and its application to guideline concordant 🦀care #precisiononcology @OHSUKnight @curecc nature.com/articles/s4159…

Would love to be there for this! Perhaps could be persuaded to attend @alpshpb next year and present the same?

The 2025 WSES #Appendicitis guidelines recommend risk stratification and imaging for diagnosis, outpatient antibiotics for uncomplicated cases, and laparoscopic surgery within 24 hours for surgical management. ja.ma/4sjm7SQ

How long should prophylactic antibiotics be used after pancreaticoduodenectomy following biliary drainage? A new study shows that a 3-day course significantly reduces surgical site infections compared to the standard 24-hour duration, lowering infection rates from 32% to 14%.👍 onlinelibrary.wiley.com/doi/10.1002/ag… #SoMe4Surgery @JSHBPS #SoMe4HPB #AGSurg

🚀 Ready to break into surgical oncology research? Join our @SurgOncTA webinar to learn how to navigate the field, unlock opportunities, and accelerate your research journey. 📅 Date: TUESDAY, 31st MARCH ⏰ Time: 7:00 PM (UK Time) 💻 Online | Free Registration 🎯 Who should attend? Medical students, Residents considering a research degree before specialty training, Those considering going Out of Programme for Research (OOPR) Register: us02web.zoom.us/webinar/regist…

Cholangiocarcinoma 2026: status quo, unmet needs and priorities ⁦@NaturePortfolio⁩ nature.com/articles/s4157…

How I Approach It: Endoscopic Approach to Palliation of Pancreatic Cancer Christina S. Gainey, MD & Todd H. Baron, MD 📕 doi.org/10.14309/ajg.0… @CGaineyMD @EndoTx @MLongMD @JasmohanBajaj

Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy ⁦@AnnSurgOncol⁩ link.springer.com/article/10.124…

Operable pancreatic cancer in the CASSANDRA era: time to rethink the algorithm New commentary in Journal of Clinical Oncology by Fausto Petrelli & Lorenzo Dottorini explores how emerging data reshape perioperative strategies for #PancreaticCancer. Key insights: 🔹 Up-front surgery + adjuvant mFOLFIRINOX remains the reference for fit, standard-risk resectable PDAC. 🔹 Neoadjuvant therapy is increasingly favored in biologically high-risk or borderline resectable disease. 🔹 The CASSANDRA trial suggests PAXG may improve event-free survival vs mFOLFIRINOX in neoadjuvant settings, though OS data remain immature. 📌 The future is risk-adapted therapy, integrating tumor biology, patient fitness, and multidisciplinary decision-making. 🔗 ascopubs.org/doi/10.1200/JC… @JCO_ASCO @ASCO @EileenMOReilly @KimmieNgMD @CathyEngMD #GIOncology #OncoTwitter

Neoadjuvant gemcitabine–oxaliplatin, lenvatinib, and anti–PD-1 antibody led to longer event-free survival than surgery alone in resectable high-risk intrahepatic cholangiocarcinoma, with mainly low-grade adverse events. Full phase 2–3 ZSAB-neoGOLP trial results and Research Summary: nejm.org/doi/full/10.10…

Circulating tumour DNA offers a minimally invasive approach for early detection of cancer, monitoring molecular residual disease, assessing molecular response and identifying treatment resistance. Check out this cutting-edge new review on ctDNA! bmjoncology.bmj.com/content/5/1/e0…

Huge congratulations to this year’s Roux Prize winners – a fantastic achievement and very well deserved! 👏 And congratulations to ASiT on delivering an incredible 50th conference. A brilliant milestone and a great event celebrating the surgical community. 🎉 #ASiT50

KRAS, once considered undruggable in cancer, has finally become actionable. Read this new cutting-edge review. bmjoncology.bmj.com/content/4/1/e0…

The future of #cholangiocarcinoma and #GBCA management @curecc @cureGBC Key 🔑 elements include periop systemic and locoregional therapy & #transplantoncology guided by molecular profiling 🩸🧬 and RCTs @OHSUKnight #GiveCancerHell We can do this 👍🏽 nature.com/articles/s4157…

Mr Arjun Takhar provides the expert surgical opinion for this evening's #HPBCases as part of the @EAHPBA Online Academy series. An interesting discussion on managing a complicated HPB patient with @somaiaharoori

🦾 Robotic Left Hepatectomy and Lymphadenectomy 💥 Intrahepatic cholangiocarcinoma 📽️ full video: youtu.be/MOng02-zwJA

✨ HPB Cases Webinar How to deal with serious post pancreatoduodenectomy complications? Real cases, expert perspectives, and practical discussion. 📅 26 Feb 2026 | ⏰ 18:00 CET 🔗 Register here: eahpba.org/education-and-… #EAHPBA #HPBCases #SurgicalEducation #Webinar

We love to see @DukeSurgOnc go international! @michael_lidsky was at @alpshpb meeting last week talking modern day outcomes from new HAI centers, the international HAI consortium, and the pressing need for modern day trials, including EA2222! (bit.ly/ea2222-pump) @eaonc

📢 Abstract submissions are now OPEN for #BASO2026!Join us at the 88th @BASO_ACS Annual Scientific Meeting in London as we explore 'Scalpel to Software — an evolution' of surgical oncology.🔹 Present your work (oral & poster sessions) 🔹 Compete for prestigious prizes 🔹 Connect with leaders in cancer surgery 🔹 Discover cutting-edge research & innovation 🔹 All cancer-related topics welcome📅 Deadline: 31 May 2026 🔗 Submit here: app.oxfordabstracts.com/auth?redirect=… Be part of shaping the future of cancer surgery. @ABSGBI @ACPGBI @asgbi @Augishealth @SurgOncTA @BAETS_UK @BAUSurology @BAOMSOfficial @BAHNOOfficial @BAPRASvoice @BGCS_org @BNOSofficial @BjsOpen @ejsotweets @BSG_Conference @The_SBNS @SCTSUK @RCSnews @RCSI_Irl @rcpsglasgow @RCSEd

Narrated Robotic Left Hemihepatectomy for Cholangiocarcinoma youtu.be/A9pD6odQg1I?si… via @YouTube